Neuropsychiatric manifestations in rheumatoid arthritis

Autoimmunity Reviews

Volumn 14, Issue 12, 2015, Pages 1116-1122

  Joaquim, Andrei F ^a   Appenzeller, Simone ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Brain; Cervical spine; Neurological manifestations; Peripheral neuropathy; Rheumatoid arthritis

Indexed keywords

AUTOANTIBODY;

ATLANTOAXIAL SUBLUXATION; BEHAVIOR CHANGE; CARPAL TUNNEL SYNDROME; CHRONIC DISEASE; COGNITIVE DEFECT; CUBITAL TUNNEL SYNDROME; DEPRESSION; HEADACHE; HUMAN; INFLAMMATION; JOINT DESTRUCTION; MENINGOENCEPHALITIS; METATARSALGIA; MONONEUROPATHY MULTIPLEX; MYELITIS; NERVE COMPRESSION; NEUROPSYCHIATRY; NORMOTENSIVE HYDROCEPHALUS; PERIPHERAL NEUROPATHY; REVIEW; RHEUMATOID ARTHRITIS; SEIZURE; SENSORIMOTOR NEUROPATHY; SPINAL CORD COMPRESSION; TARSAL TUNNEL SYNDROME; ARTHRITIS, RHEUMATOID; BRAIN; COMPLICATION; IMMUNOLOGY; SPINE;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BRAIN; COGNITION DISORDERS; DEPRESSION; HEADACHE; HUMANS; SPINE;

EID: 84945497319     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.07.015     Document Type: Review

References (96)

1. Scott D.L., Wolfe F., Huizinga T.W. Rheumatoid arthritis. Lancet 2010, 376:1094-1108.
2. Turesson C., O'Fallon W.M., Crowson C.S., Gabriel S.E., Matteson E.L. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002, 29:62-67.
3. Krauss W.E., Bledsoe J.M., Clarke M.J., Nottmeier E.W., Pichelmann M.A. Rheumatoid arthritis of the craniovertebral junction. Neurosurgery 2010, 66:83-95.
4. Covic T., Cumming S.R., Pallant J.F., Manolios N., Emery P., Conaghan P.G., et al. Depression and anxiety in patients with rheumatoid arthritis: prevalence rates based on a comparison of the Depression, Anxiety and Stress Scale (DASS) and the hospital, Anxiety and Depression Scale (HADS). BMC Psychiatry 2012, 24:12-16.
5. Uguz F., Akman C., Kucuksarac S., Tufekci O. Anti tumor necrosis factor therapy is associated with less frequent mood and anxiety disorders in patients with rheumatoid arthritis. Psychiatry Clin Neurosci 2009, 63:50-55.
6. Clark L., Watson D. Tripartite model of anxiety and depression: psychometric evidence and taxonomic implications. J Abnorm Psychol 1991, 100:316-6.
7. Bartolini M., Candela M., Brugni M., Catena L., Mari F., Pomponio G., et al. Are behaviour and motor performances of rheumatoid arthritis patients influenced by subclinical cognitive impairments? A clinical and neuroimaging study. Clin Exp Rheumatol 2002, 20:491-497.
8. Appenzeller S., Bertolo M.B., Costallat L.T. Cognitive impairment in rheumatoid arthritis. Methods Find Exp Clin Pharmacol 2004, 26:339-343.
9. Prete M., Racanelli V., Digiglio L., Vacca A., Dammacco F., Perosa F. Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmun Rev 2011, 11:123-131.
10. Makol A., Crowson C.S., Wetter D.A., Sokumbi O., Matteson E.L., Warrington K.J. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford) 2014, 53:890-899.
11. Kurne A., Karabudak R., Karadag O., Yalcin-Cakmakli G., Karli-Oguz K., Yavuz K., et al. An unusual central nervous system involvement in rheumatoid arthritis: combination of pachymeningitis and cerebral vasculitis. Rheumatol Int 2009, 29:1349-1353.
12. Olsen M.L., O'Connor S., Arnett F.C., Rosenbaum D., Grotta J.C., Warner N.B. Autoantibodies and rheumatic disorders in a neurology inpatient population: a prospective study. Am J Med 1991, 90:479-488.
13. Ramos-Remus C., Duran-Barragan S., Castillo-Ortiz J.D. Beyond the joints: neurological involvement in rheumatoid arthritis. Clin Rheumatol 2012, 31:1-12.
14. Muhammed N., Campbell P., Smith I.S. Peripheral nerve entrapment syndromes: diagnosis and management. Br J Hosp Med 1995, 53:141-146.
15. Joaquim A.F., Ghizoni E., Tedeschi H., Appenzeller S., Riew K.D. Radiological evaluation of cervical spine involvement in rheumatoid arthritis. Neurosurg Focus 2015, 38:E4.
16. Joaquim A.F., Appenzeller S. Cervical spine involvement in rheumatoid arthritis-a systematic review. Autoimmun Rev 2014, 13:1195-1202.
17. Lee D.M., Weinblatt M.E. Rheumatoid arthritis. Lancet 2001, 358:903-911.
18. Gkaliagkousi E., Gavriilaki E., Doumas M., Petidis K., Aslanidis S., Stella D. Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management. J Clin Rheumatol 2012, 18:422-430.
19. Maradit-Kremers H., Nicola P.J., Crowson C.S., Ballman K.V., Gabriel S.E. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005, 52:722-732.
20. Rimón R., Laakso R.L. Overt psychopathology in rheumatoid arthritis. A fifteen-year follow-up study. Scand J Rheumatol 1984, 13:324-328.
21. Rogers M.P., Reich P., Kelly M.J., Liang M.H. Psychiatric consultation among hospitalized arthritis patients. Gen Hosp Psychiatry 1980, 2:89-94.
22. Gardiner B.M. Psychological aspects of rheumatoid arthritis. Psychol Med 1980, 10:159-163.
23. Gettings L. Psychological well being in rheumatoid arthritis: a review of the literature. Musculoskeletal Care 2010, 8:99-106.
24. Dickens C., McGowan L., Clark-Carter D., Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002, 64:52.
25. Wolfe F., Michaud K. Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity. Arthritis Care Res 2009, 61:667-673.
26. Robinson R.G., Spalletta G. Poststroke depression: a review. Can J Psychiatry 2010, 55:341-349.
27. Wang S.L., Chang C.H., Hu L.Y., Tsai S.J., Yang A.C., You Z.H. Risk of developing depressive disorders following rheumatoid arthritis: a nationwide population-based study. PLoS One 2014, 9:e107791.
28. Matcham F., Rayner L., Steer S., Hotopf M. The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology 2013, 52:2136-2148.
29. Matcham F., Ali S., Hotopf M., Chalder T. Psychological correlates of fatigue in rheumatoid arthritis: a systematic review. Clin Psychol Rev 2015, 39:16-29.
30. Timonen M., Viilo K., Hakko H., Sarkioja T., Ylikulju M., Meyer-Rochow V., et al. Suicides in persons suffering from rheumatoid arthritis. Rheumatology 2003, 42:287-291.
31. Mok C.C., Lok E.Y., Cheung E.F. Concurrent psychiatric disorders are associated with significantly poorer quality of life in patients with rheumatoid arthritis. Scand J Rheumatol 2012, 41:253-259.
32. Liu Y., Ho R.C., Mak A. The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis. Int J Rheum Dis 2012, 15:183-187.
33. Lopresti A.L., Maker G.L., Hood S.D., Drummond P.D. A review of peripheral biomarkers in major depression: the potential of inflammatory and oxidative stress biomarkers. Prog Neuropsychopharmacol Biol Psychiatry 2014, 48:102-111.
34. Cabrera-Marroquín R., Contreras-Yáñez I., Alcocer-Castillejos N., Pascual-Ramos V. Major depressive episodes are associated with poor concordance with therapy in rheumatoid arthritis patients: the impact on disease outcomes. Clin Exp Rheumatol 2014, 32:904-913.
35. Ciriaco M., Ventrice P., Russo G., Scicchitano M., Mazzitello G., Scicchitano F., et al. Corticosteroid-related central nervous system side effects. J Pharmacol Pharmacother 2013, 4:S94-S98.
36. Frank R.G., Beck N.C., Parker J.C., Kashani J.H., Elliot T.R., Haut A.E., et al. Depression in rheumatoid arthritis. J Rheumatol 1988, 15:920-925.
37. Liang M.H., Rogers M., Larson M., Eaton H.M., Murawski B.J., Taylor J.E., et al. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1984, 27:13-19.
38. Shin S.Y., Katz P., Wallhagen M., Julian L. Cognitive impairment in persons with rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012, 64:1144-1150.
39. Sato H., Kobayashi D., Abe A., Ito S., Ishikawa H., Nakazono K., et al. Tocilizumab treatment safety in rheumatoid arthritis in a patient with multiple sclerosis: a case report. BMC Res Notes 2014, 7:641.
40. Quinn C.T., Kamen B.A. A biochemical perspective of methotrexate neurotoxicity with insight on nonfolate rescue modalities. J Investig Med 1996, 44:522-530.
41. Kur-Zalewska J., Swarowska-Knap J., Tłustochowicz W. Neurological disorders with demyelinating brain white matter lesions in a patient with rheumatoid arthritis treated with etanercept. Pol Arch Med Wewn 2008, 118:234-237.
42. Mok C.C. Rituximab for the treatment of rheumatoid arthritis: an update. Drug Des Devel Ther 2013, 8:87-100.
43. Schwartz N., Mitnick H.J., Nowatzky J. Headaches related to rheumatologic disease. Curr Pain Headache Rep 2013, 17:381.
44. Zhou H.X., Ning G.Z., Feng S.Q., Jia H.W., Liu Y., Feng H.Y., et al. Cryptococcosis of lumbar vertebra in a patient with rheumatoid arthritis and scleroderma: case report and literature review. BMC Infect Dis 2013, 13:128.
45. de Morais S.S., Mafra Mde O., Canterle E.M., de Lima L.L., Ribeiro S.L. Histoplasmosis mimicking tuberculosis spondylodiscitis in a patient with rheumatoid arthritis. Acta Reumatol Port 2008, 33:360-363.
46. Zorlu M., Kiskac M., Karatoprak C., Cakirca M., Yavuz E., Cetin G., et al. Pott's disease and hypercalcemia in a patient with rheumatoid arthritis receiving methotrexate monotherapy. Indian J Pharmacol 2013, 45:631-633.
47. Cantini F., Nannini C., Niccoli L., Iannone F., Delogu G., Garlaschi G., et al. Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmun Rev 2015, 14:503-509.
48. Verheyen J., Maizus K., Feist E., Tolman Z., Knops E., Saech J., et al. Increased frequency of JC-polyomavirus detection in rheumatoid arthritis patients treated with multiple biologics. Med Microbiol Immunol Feb 13 2015, (Epub ahead for print).
49. Rubbert-Roth A. Assessing the safety of biologic agents in patients with rheumatoid arthritis. Rheumatology (Oxford) 2012, 51:38-47.
50. Lu L., Chwalisz B., Pfannl R., Narayanaswami P. Rheumatoid meningitis: a rare complication of rheumatoid arthritis. BMJ Case Rep Jul 1 2015.
51. Starosta M.A., Brandwein S.R. Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 2007, 68:1079-1080.
52. Tan H.J., Raymond A.A., Phadke P.P., Rozman Z. Rheumatoid pachymeningitis. Singapore Med J 2004, 45:337-339.
53. Servioli M.J., Chugh C., Lee J.M., Biller J. Rheumatoid meningitis. Front Neurol Dec 2011, 26:2-84.
54. Radic M., Martinovic Kaliterna D., Radic J. Overview of vasculitis and vasculopathy in rheumatoid arthritis-something to think about. Clin Rheumatol 2013, 32:937-942.
55. Guadalupe Loya-de la Cerda D., Avilés-Solís J.C., Delgado-Montemayor M.J., Camara-Lemarroy C.R., Galarza-Delgado D.Á. Isolated rheumatoid arthritis-associated cerebral vasculitis: a diagnostic challenge. Joint Bone Spine 2013, 80:88-90.
56. del Rincon I.D., Williams K., Stern M.P., Freeman G.L., Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001, 44:2737-2745.
57. Neamtu L., Belmont M., Miller D.C., Leroux P., Weinberg H., Zagzag D. Rheumatoid disease of the CNS with meningeal vasculitis presenting with a seizure. Neurology 2001, 56:814-815.
58. Bourgeois P., Rivest J., Bocti C. Rheumatoid meningitis presenting with stroke-like episodes. Neurology 2014, 82:1564-1565.
59. Beck D.O., Corbett J.J. Seizures due to central nervous system rheumatoid meningovasculitis. Neurology 1983, 33:1058-1061.
60. Richioud B., Béjot Y., Ornetti P., Ricolfi F., Sautreaux J.L., Ben Salem D. Rheumatoid arthritis and meningeal nodules. Rev Neurol (Paris) 2012, 168:350-356.
61. Thomas E., Leroux J.L., Hellier J.P., Blotman F. Seizure and methotrexate therapy in rheumatoid arthritis. J Rheumatol Sep 1993, 20:1632.
62. Hill M.E., Gordon C., Situnayake R.D., Heath D.A. Sulfasalazine induced seizures and dysphasia. J Rheumatol 1994, 21:748-749.
63. Markusse H.M., Hilkens P.H., van den Bent M.J., Vecht C.J. Normal pressure hydrocephalus associated with rheumatoid arthritis responding to prednisone. J Rheumatol 1995, 22:342-343.
64. Catananti C., Mastropaolo S., Calabrese C., Silveri M.C., Onder G. A case of normal-pressure hydrocephalus associated with rheumatoid arthritis. Aging Clin Exp Res 2010, 22:189-191.
65. Yokoyama W., Takada K., Miyasaka N., Kohsaka H. Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis. BMJ Case Rep Aug 1 2014, 10.1136/bcr-2014-20779.
66. Kaltsonoudis E., Zikou A.K., Voulgari P.V., Konitsiotis S., Argyropoulou M.I., Drosos A.A. Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther 2014, 16:R125.
67. Seror R., Richez C., Sordet C., Rist S., Gossec L., Direz G., et al. Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey. Rheumatology (Oxford) 2013, 52:868-874.
68. Faillace C., de Almeida J.R., de Carvalho J.F. Optic neuritis after infliximab therapy. Rheumatol Int 2013, 33:1101-1103.
69. Kaltsonoudis E., Voulgari P.V., Konitsiotis S., Drosos A.A. Demyelination and other neurological adverse events after anti-TNF therapy. Autoimmun Rev 2014, 13:54-58.
70. Hrycaj P., Korczowska I., Łacki J.K. Severe Parkinson's disease in rheumatoid arthritis patient treated with infliximab. Rheumatology (Oxford) 2003, 42:702-703.
71. Kogure T., Tatsumi T., Kaneko Y., Okamoto K. Rheumatoid arthritis accompanied by Parkinson disease. J Clin Rheumatol 2008, 4:192-193.
72. Aguilar-Amat M.J., Abenza-Abildúa M.J., Vivancos F., Rodríguez de Rivera F.J., Morales-Bastos C., Gandía-Gonzalez M.L., et al. Rheumatoid meningitis mimicking progressive supranuclear palsy. Neurologist 2011, 17:136-140.
73. Blom M., Creemers M.C., Kievit W., Lemmens J.A., van Riel P.L. Long-term follow-up of the cervical spine with conventional radiographs in patients with rheumatoid arthritis. Scand J Rheumatol 2013, 42:281-288.
74. Yurube T., Sumi M., Nishida K., Miyamoto H., Kohyama K., Matsubara T., et al. Kobe Spine Conference. Incidence and aggravation of cervical spine instabilities in rheumatoid arthritis: a prospective minimum 5-year follow-up study of patients initially without cervical involvement. Spine (Phila Pa 1976) 2012, 37:2136-2144.
75. Yurube T., Sumi M., Nishida K., Takabatake M., Kohyama K., Matsubara T., et al. Kobe Spine Conference. Progression of cervical spine instabilities in rheumatoid arthritis: a prospective cohort study of outpatients over 5years. Spine (Phila Pa 1976) 2011, 36:647-653.
76. Brode S.K., Jamieson F.B., Ng R., Campitelli M.A., Kwong J.C., Paterson J.M., et al. Increased risk of mycobacterial infections associated with anti-rheumatic medications. Thorax 2015, 70:677-682.
77. Sakai T., Sairyo K., Hamada D., Higashino K., Katoh S., Takata Y., et al. Radiological features of lumbar spinal lesions in patients with rheumatoid arthritis with special reference to the changes around intervertebral discs. Spine J 2008, 8:605-611.
78. Lee S.H., Kang Y.M., Park Y.M. Multiple vertebral involvement of rheumatoid arthritis in thoracolumbar spine: a case report. J Korean Med Sci 2010, 25:472-475.
79. Kawaji H., Miyamoto M., Gembun Y., Ito H. A case report of rapidly progressing cauda equina symptoms due to rheumatoid arthritis. J Nippon Med Sch 2005, 72:290-294.
80. Sim M.K., Kim D.Y., Yoon J., Park D.H., Kim Y.G. Assessment of peripheral neuropathy in patients with rheumatoid arthritis who complain of neurologic symptoms. Ann Rehabil Med 2014, 38:249-255.
81. Bayrak A.O., Durmus D., Durmaz Y., Demir I., Canturk F., Onar M.K. Electrophysiological assessment of polyneurophatic involvement in rheumatoid arthritis: relationships among demographic, clinical and laboratory findings. Neurol Res 2010, 32:711-714.
82. LeBlanc K.E., Cestia W. Carpal tunnel syndrome. Am Fam Physician 2011, 83:952-958.
83. Massy-Westropp N., Grimmer K., Bain G. A systematic review of the clinical diagnostic tests for carpal tunnel syndrome. J Hand Surg 2000, 25:120-127.
84. Malipeddi A., Reddy V.R., Kallarackal G. Posterior interosseous nerve palsy: an unusual complication of rheumatoid arthritis: case report and review of the literature. Semin Arthritis Rheum 2011, 40:576-579.
85. Kalaci A., Aslan B., Yanat A.N. Spontaneous rupture of ulnar nerve due to neglected cubital tunnel syndrome associated with rheumatoid arthritis. J Clin Rheumatol 2007, 13:217-218.
86. Grabois M., Puentes J., Lidsky M. Tarsal tunnel syndrome in rheumatoid arthritis. Arch Phys Med Rehabil 1981, 62:401-403.
87. Baylan S.P., Paik S.W., Barnert A.L., Ko K.H., Yu J., Persellin R.H. Prevalence of the tarsal tunnel syndrome in rheumatoid arthritis. Rheumatol Rehabil 1981, 20:148-150.
88. Chaganti S., Joshy S., Hariharan K., Rashid M. Rheumatoid nodule presenting as Morton's neuroma. J Orthop Traumatol 2013, 14:219-222.
89. Agarwal V., Singh R., Wiclaf, Chauhan S., Tahlan A., Ahuja C.K., et al. A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin Rheumatol 2008, 27:841-844.
90. Koike H., Watanabe H., Sobue G. The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features. J Neurol Neurosurg Psychiatry 2013, 84:98-106.
91. Makol A., Grover M. Adalimumab induced mononeuritis multiplex in a patient with refractory rheumatoid arthritis: a case report. Cases J 2008, 1:287.
92. Gorson K.C. Vasculitic neuropathies: an update. Neurologist 2007, 13:12-19.
93. Conn D.L., McDuffie F.C., Pj Dyc Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum 1972, 15:135-143.
94. Puechal X., Said G., Hilliquin P., Coste J., Job-Deslandre C., Lacroix C., et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995, 38:1618-1629.
95. Alshekhlee A., Basiri K., Miles J.D., Ahmad S.A., Katirji B. Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists. Muscle Nerve 2010, 41:723-727.
96. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000, 343:847-855.